EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Sch... ( BOSTON April 2 2008 /- EnVivo Pha...)

HOME >> MEDICINE >> TECHNOLOGY

EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia

Date:4/2/2008

BOSTON, April 2, 2008 /PRNewswire/ -- EnVivo Pharmaceuticals announced today that it has initiated a clinical safety and biomarker study of its alpha-7 nicotinic agonist (EVP-6124) in Schizophrenia patients chronically treated with atypical antipsychotic medications. The objectives of this study are to evaluate the safety of multiple doses of EVP-6124 in this patient population, to investigate potential drug-drug interactions, and to determine the effects of EVP-6124 on sensitive electrophysiology markers (the P50 auditory evoked response and mismatch negativity) in Schizophrenia patients.

The principle investigator is Dr. Sheldon H. Preskorn and the study is being conducted at the Clinical Research Institute (CRI) in Wichita, Kansas. Dr. Preskorn is Chief Executive Officer and Medical Director of the CRI which specializes in early clinical pharmacology studies in patients with psychiatric and neurologic diseases. Dr. Preskorn is also a Professor in the Department of Psychiatry and Behavioral Sciences at the Kansas University of School of Medicine - Wichita.

This trial is enrolling approximately 20 Schizophrenia patients treated with a stable dose of an atypical antipsychotic drug. Patients are receiving one of two doses of EVP-6124 or a placebo for up to 28 days. Previous Phase I studies have characterized the safety and cognitive effects of single and multiple EVP-6124 doses as low as 0.1 mg/day. Based on these studies, two doses of EVP-6124 within the expected efficacy range are being examined in this ongoing study. The results of this safety and biomarker trial will be used to design larger Phase II studies of EVP-6124 in patients with Schizophrenia. These trials will be initiated later in 2008 or in early 2009.

"Our extensive Phase I work has paid off," remarked Kees Been, President and CEO of EnVivo. "We already have results that suggest that EVP-6124 is associated with cognitive benefits in learning and memory and we believe we und
'/>"/>

SOURCE EnVivo Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related medicine technology :

1. EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimers, Schizophrenia and Huntingtons Diseases
2. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
3. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
4. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
5. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
6. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
7. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
8. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
9. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
10. VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial
11. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting

Post Your Comments:

(Date:11/27/2009)...ewswire-FirstCall/ -- Booth - 3646/South Hall A - ...mier supplier of X-ray tubes and flat panel digita...detectors at the RSNA Annual Meeting in Chicago, I...ill also be exhibiting X-ray tube technology for m...reatment technologies. ,, Varian,s exhibit wil...

(Date:11/27/2009)...e/ -- At the upcoming Radiological Society of Nort...oyal Philips Electronics ( PHG, AEX: PHI) will dem...ormatics solutions designed to directly address th...livering meaningful imaging innovations that refle...sy upgradability. This focus will enable Philips ...

(Date:11/25/2009)... Praxis Electronic Medical Records ...emy of Family Physicians, (AAFP) Family Practice M...for improving medical quality, health maintenance,... Stimulus legislation. Praxis also ranked #1 among...t in determining their salary. Finally, Praxis als...

Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2 Philips Helps Hospitals Strike Balance Between Innovation and Value 2 Philips Helps Hospitals Strike Balance Between Innovation and Value 3 Philips Helps Hospitals Strike Balance Between Innovation and Value 4 Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2 Tobira Therapeutics Inc Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK 652 for the Treatment of HIV 13130 1 Tobira Therapeutics Inc Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK 652 for the Treatment of HIV 13130 2 Scripps led study shows ocean health plays vital role in coral reef recovery 9308 1 Scripps led study shows ocean health plays vital role in coral reef recovery 9308 2 BET Networks Airs Special Coverage of President Obamas News Conference on Health Care 52333 1 BET Networks Airs Special Coverage of President Obamas News Conference on Health Care 52333 2

[0] Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago [0] Philips Helps Hospitals Strike Balance Between Innovation and Value [0] Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey

...ties of Red Hot ,Super,Fruit, SAN DIEGO, April 6,...s,one of today,s hottest "Super Fruits," may help ...of type 2 diabetes and cardiovascular disease,in a...ichigan researchers,today at the Experimental Biol... inflammation may be a marker for many chronic dis...

...Scientific Inc. (NYSE: TMO ), the world leader in....S. Food and Drug Administration (FDA) clearance f... methicillin-resistant,Staphylococcus aureus (MRSA... highest Positive Predictive Value commercially av...ate results within 24 hours. The Spectra,MRSA test...

Other Medicine Technology:Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease 2 Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease 3 Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 2 Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 3 Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 4

Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium

(Date:11/28/2009)...RNewswire/ -- Get ready for advanced visualizat...ine when Siemens introduces syngo. via(1)...ing of the Radiological Society of North America (...Place (Booth #825, East Building/Lakeside Center, ...ens, new imaging software for multimodality readin...

(Date:11/28/2009)...pirits, recognize signs of depression , ,...eniors, the holiday season can trigger melancholy ... health issues or worry about money problems, acco...help overcome the seasonal blues, the AGS Foundati...: , Get out and socialize or invite family and f...

(Date:11/27/2009)... firm Replikins Ltd. today issued its latest bioch...t shows that the lethality of the virus has droppe...,s current outbreak in the spring of 2009 to resti.... The H1N1 infectivity count, however, remains inc...November 27, 2009 -- Biotech firm Replikins Ltd., ...

(Date:11/27/2009)... 27 Preventing disease ...unately every year, new vaccines are being added t...s boost immunity for the same period of time? And,...d to keep immunity strong? ,, In this month,s...Academy of Pediatrics, Michael Pichichero MD, Dire...

(Date:11/27/2009)...e Holdings has announced that it has become a nati...he largest nonprofit organizations dedicated to ar... Delray Beach, FL (Vocus) No... XCHO), a company specializing in the marketing an...cts, has announced today that is has become a nati...

Breaking Medicine News(10 mins):Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2 Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3 Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4 Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5 Health News:Seniors May Need Help Overcoming Holiday Blues 2 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4 Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5 Health News:Why Some Vaccines May Require A Booster 2 Health News:Why Some Vaccines May Require A Booster 3 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4

[0] Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via [1] Seniors May Need Help Overcoming Holiday Blues [0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased [0] Why Some Vaccines May Require A Booster [0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation

..., June 12, 2008 A material designed to prevent ad...rsity Prof. Daniel Cohn of the Casali Instititue o...e Awards for Innovation. The awards were presented...ar weight) that generate a physical barrier betwee...

...nce, Thursday 12 June 2008: Low bone mineral densi...tality in patients with rheumatoid arthritis (RA) ...new study presented today at EULAR 2008, the Annua...ffective predicting mortality as well-established ...

... 12 /Xinhua-PRNewswire-FirstCall/ -- China Medical... ), a leading China-based,medical device company t...-,vitro diagnostic products and high intensity foc...scal year ended,March 31, 2008 ("FY2007")., 4Q F...

...h., June 12 A few months ago, members of,Congress...a misperception,of many Americans approaching reti...dicare would cover their long-term care expenses,".... "It wasn,t,so, but the wording of the Social Sec...

...R, Ill. Delaying an adolescents school start time...ognitive performance, according to a research abst...008, the 22nd Annual Meeting of the Associated Pro...m two classes, who were divided into experimental ...

...R, Mich. A type of stroke that can strike at any ...o be more common in women and Mexican-Americans th...tudy from the University of Michigan Stroke Progra... type of stroke related to a ruptured brain aneury...

Invention to prevent surgical adhesions wins Kaye Award Hand bone mineral density is an effective predictor of mortality in rheumatoid arthritis China Medical Technologies Reports Fourth Quarter and Full Year Financial Results Social Security Statement Advises Seniors to Consider Private Long-Term Care Insurance, LTC Agency Reports; Medicare Won't Cover It Delaying school start time by one hour positively affects adolescents' cognitive performance Women, Mexican-Americans at higher risk of ruptured brain aneurysm

...boratory," it brings to mind images of test tubes,...tems. With the introduction of the Brady Code Read... list of critical lab tools. Brady Corporation has...he lab with the introduction of the CR2. It is the...

VisionMate1

Laboratory Table; Sealed Laminate Top

Tables

Medicine Products:

Code Reader 2 Scanner VisionMate1 Laboratory Table; Sealed Laminate Top Tables

EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Sch...( BOSTON April 2 2008 /- EnVivo Pha...),Health